Product Information
ROPINIROLE HCL ER 4 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5060 per EA under NDC 62332010830. Its NADAC has been published 284 times since Mar 17, 2021.
FDA first approved this application on Apr 22, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332010830
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202786FDA Approved
4/22/2013
TE Code
AB
On Market Since
6/20/2020
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 4 MG TABLET has been published 284 times since Mar 17, 2021, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5060 per EA |
|---|---|
| All-time high | $1.3871 (Sep 15, 2021) |
| All-time low | $0.4819 (Nov 20, 2024) |
| 52-week high | $0.8533 |
| 52-week low | $0.5060 |
| Median price | $0.8007 |
| Average price | $0.8092 |
| Largest weekly change | +72.2% (Oct 19, 2022) |
| Weeks tracked | 284 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 4 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.5060 per EA (NDC 62332010830), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has declined 58.4%. It has been tracked across 284 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 4 MG TABLET?
Since Mar 17, 2021, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has ranged from a low of $0.4819 (Nov 20, 2024) to a high of $1.3871 (Sep 15, 2021), with a median of $0.8007 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 4 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROPINIROLE HCL 4 MG TABLET, is $0.0818 per EA — about 84% below ROPINIROLE HCL ER 4 MG TABLET.
Who manufactures ROPINIROLE HCL ER 4 MG TABLET?
ROPINIROLE HCL ER 4 MG TABLET (NDC 62332010830) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.